BioXcel Therapeutics, Inc. (BTAI) announced Loss for fourth quarter of -$10.86 million
The company's bottom line came in at -$10.86 million, or -$3.57 per share. This compares with -$22.26 million, or -$12.09 per share, last year.
The company's revenue for the period fell 2.6% to $0.37 million from $0.38 million last year.
BioXcel Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$10.86 Mln. vs. -$22.26 Mln. last year.
-EPS: -$3.57 vs. -$12.09 last year.
-Revenue: $0.37 Mln vs. $0.38 Mln last year.
For comments and feedback: editorial@rttnews.com